Vice President, Oncology Breast Therapeutic Area Medical Head, MD

Vice President, Oncology Breast Therapeutic Area Medical Head, MD

United States - Washington – Bothell
United States - New York - New York City
United States - Massachusetts - Cambridge
We're in relentless pursuit of breakthroughs that change patients' lives. We innovate every day to make the world a healthier place.

To fully realize Pfizer's purpose – Breakthroughs that change patients' lives – we have established a clear set of expectations regarding "what" we need to achieve for patients and "how" we will go about achieving those goals.

Pfizer offers competitive compensation and benefits programs designed to meet the diverse needs of our colleagues.

Today, Pfizer Oncology has an industry-leading portfolio of 25 approved innovative cancer medicines, including major therapies for metastatic breast cancer, prostate cancer, urothelial carcinoma and haemato-oncological malignancies.

Pfizer's in-line portfolio is focused on four broad, key areas: breast cancer, genitourinary cancer, hematology and precision medicine, complemented by an extensive pipeline of over 50 programs in clinical development.

The Breast TA Medical Head, VP will report to the Head of Oncology Medical, Pfizer Oncology.

The incumbent will lead the Global Medical Strategy Heads and the Global Medical Strategy Directors for late-stage development and in-line breast cancer assets to establish and develop medical strategy at an asset, modality, and TA level, in close collaboration with senior Pfizer Oncology stakeholders.

As a senior and respected subject matter expert in the clinical Oncology community, the incumbent will drive Pfizer's presence and reputation within the oncology clinical community and be a 'go to' person for key opinion leaders (KOLs) in their therapeutic area.

The position has broad impact throughout the organization and requires an oncology medical professional with an understanding of pharmaceutical business operations (including product development), products, strategic thinking skills, leadership ability, and strong knowledge about and relationships within the external oncology stakeholder community.

The leader will build and develop a team of medical oncology experts that have strong knowledge in oncology, including the business environment, disease state, competitor data, asset data and synthesize into clear and effective medical strategy, enabling the effective pull through by the Medical Affairs local teams to unlock the full global potential of our existing and future commercially available medicines.

The role will partner closely with Pfizer Oncology stakeholder groups (including Research, Early and Late Development, Regulatory Strategy, Clinical Development and Operations, Translational Oncology, US Medical Affairs, etc.), International Oncology Medical Affairs, Pfizer Research & Development (PRD) cross-TA global Medical platforms, Worldwide Medical, Drug Safety Research and Development and Safety in order to drive TA Medical Strategy across the organization.

ROLE RESPONSIBILITIES

This position reports directly to Head of Oncology Medical, Pfizer Oncology and is a member of the Oncology Medical Leadership Team (LT).

This Leader is accountable for the development of the global therapeutic area medical strategy and execution of individual programs for late stage and in-line breast cancer development assets, translating cross functional and geographic needs, and clinical / health system stakeholder insights into actionable research and medical deliverables to support the lightspeed development of innovative cancer medicines that takes on the world's biggest cancers and reaches every last patient faster.

Executive Medical Strategy leadership including:
Leadership of Medical Strategy on Pfizer Oncology governance committees.

Partnership with Oncology Medical Affairs leaders in all geographies and cross-functionally with Commercial, and Access and Value to establish an integrated community of breast cancer experts and oversee the success of the assets within their TA of responsibility.

As a subject matter expert, this role is responsible for collaborating globally with KOLs and scientific experts to inform clinical development and medical strategies for their portfolio.

Provide oversight and monitoring of the Scientific Engagement Program for their portfolio in collaboration with Medical Affairs leadership.

Ensure the TA and asset medical strategies deliver end to end medical excellence, starting with early development and continuing through the development lifecycle of the brand.

As the Medical face of the Pfizer Oncology organization for their portfolio, the incumbent will shape the evidence generation strategies in their portfolio by leveraging their deep expertise that enables the extraction of valuable medical insights from diverse stakeholders in the clinical community.

Ensure continuity in evidence generation plans and identify gaps to be addressed through clinical development, ISTs, CRCs or other Medically driven research.

Alignment of resources (direct & indirect) to facilitate quality lightspeed delivery on Pfizer Oncology priorities, in alignment with clinical development and commercial priorities.

Provide executive leadership as a portfolio liaison across clinical development partnerships and collaborations (JDC, JSC, Joint Medical Affairs Working Groups with partners).

Oversight of the creation of a compelling scientific communications and publication plan based on the clinical trials conducted within Pfizer Oncology.

Ensuring that Medical Education programs keep up with and adequately reflect the rapidly advancing scientific landscape, including innovative Oncology medicines within their therapeutic area.

Represent Pfizer and Pfizer Oncology at the leading Therapeutic Area Medical / Clinical / Scientific Conferences/Congresses, KOL Panels and Clinical Trial Steering Groups, in order to maintain and build relationships with KOLs and the wider clinical community.

Be a 'voice' for field teams within the Pfizer Oncology organization, ensuring that field medical perspectives are transmitted to discussions of clinical development are integrated into strategy development to support launch and post-launch success.

BASIC QUALIFICATIONS
Clinically trained (MD, ClinPharm), PharmD, MD-PhD desired

Oncology medical professional with strong experience (at least 9 years if MD, ClinPharm or MD-PhD, at least 15 years if PhD or PharmD) in the pharmaceutical or biopharma industry with clinical development, and/or medical affairs experience.

A leader who can work collaboratively across a complex cross functional team of stakeholders. Must be able to lead with a lightspeed, innovative, and entrepreneurial mindset.

Extensive experience and strong understanding of biopharmaceutical drug development, the competitive landscape / oncology market dynamics / evolving treatment landscape and HCP and patient insights, bringing deep clinical and external stakeholder insights to decision making.

A recognised leader in the breast cancer medical field, able to build and maintain strong relationships with senior academics, investigators and KOLs.

Proven expertise in fostering employee development and well-being through effective people development, and motivational team leadership.

A strong ability to influence all levels of the organization, including both senior-level colleagues and other levels across the company.

Must have executive leadership skills, able to lead and motivate a team of medical experts that have strong knowledge in oncology and are medical leaders on the Global Medicine Teams.

A strategic leader, able to work within a matrix organization with a high proficiency in problem solving, strong analytical skills and an ability to lead through complexity and ambiguity.

ROLE SUMMARY

Today, Pfizer Oncology has an industry-leading portfolio of 25 approved innovative cancer medicines, including major therapies for metastatic breast cancer, prostate cancer, urothelial carcinoma and haemato-oncological malignancies.

Pfizer's in-line portfolio is focused on four broad, key areas: breast cancer, genitourinary cancer, hematology and precision medicine, complemented by an extensive pipeline of over 50 programs in clinical development.

The Breast TA Medical Head, VP will report to the Head of Oncology Medical, Pfizer Oncology.

The incumbent will lead the Global Medical Strategy Heads and the Global Medical Strategy Directors for late-stage development and in-line breast cancer assets to establish and develop medical strategy at an asset, modality, and TA level, in close collaboration with senior Pfizer Oncology stakeholders.

As a senior and respected subject matter expert in the clinical Oncology community, the incumbent will drive Pfizer's presence and reputation within the oncology clinical community and be a 'go to' person for key opinion leaders (KOLs) in their therapeutic area.

The position has broad impact throughout the organization and requires an oncology medical professional with an understanding of pharmaceutical business operations (including product development), products, strategic thinking skills, leadership ability, and strong knowledge about and relationships within the external oncology stakeholder community.

The leader will build and develop a team of medical oncology experts that have strong knowledge in oncology, including the business environment, disease state, competitor data, asset data and synthesize into clear and effective medical strategy, enabling the effective pull through by the Medical Affairs local teams to unlock the full global potential of our existing and future commercially available medicines.

The role will partner closely with Pfizer Oncology stakeholder groups (including Research, Early and Late Development, Regulatory Strategy, Clinical Development and Operations, Translational Oncology, US Medical Affairs, etc.), International Oncology Medical Affairs, Pfizer Research & Development (PRD) cross-TA global Medical platforms, Worldwide Medical, Drug Safety Research and Development and Safety in order to drive TA Medical Strategy across the organization.

ROLE RESPONSIBILITIES

This position reports directly to Head of Oncology Medical, Pfizer Oncology and is a member of the Oncology Medical Leadership Team (LT).

This Leader is accountable for the development of the global therapeutic area medical strategy and execution of individual programs for late stage and in-line breast cancer development assets, translating cross functional and geographic needs, and clinical / health system stakeholder insights into actionable research and medical deliverables to support the lightspeed development of innovative cancer medicines that takes on the world's biggest cancers and reaches every last patient faster.

Executive Medical Strategy leadership including:
Leadership of Medical Strategy on Pfizer Oncology governance committees.

Partnership with Oncology Medical Affairs leaders in all geographies and cross-functionally with Commercial, and Access and Value to establish an integrated community of breast cancer experts and oversee the success of the assets within their TA of responsibility.

As a subject matter expert, this role is responsible for collaborating globally with KOLs and scientific experts to inform clinical development and medical strategies for their portfolio.

Provide oversight and monitoring of the Scientific Engagement Program for their portfolio in collaboration with Medical Affairs leadership.

Ensure the TA and asset medical strategies deliver end to end medical excellence, starting with early development and continuing through the development lifecycle of the brand.

As the Medical face of the Pfizer Oncology organization for their portfolio, the incumbent will shape the evidence generation strategies in their portfolio by leveraging their deep expertise that enables the extraction of valuable medical insights from diverse stakeholders in the clinical community.

Ensure continuity in evidence generation plans and identify gaps to be addressed through clinical development, ISTs, CRCs or other Medically driven research.

Alignment of resources (direct & indirect) to facilitate quality lightspeed delivery on Pfizer Oncology priorities, in alignment with clinical development and commercial priorities.

Provide executive leadership as a portfolio liaison across clinical development partnerships and collaborations (JDC, JSC, Joint Medical Affairs Working Groups with partners).

Oversight of the creation of a compelling scientific communications and publication plan based on the clinical trials conducted within Pfizer Oncology.

Ensuring that Medical Education programs keep up with and adequately reflect the rapidly advancing scientific landscape, including innovative Oncology medicines within their therapeutic area.

Represent Pfizer and Pfizer Oncology at the leading Therapeutic Area Medical / Clinical / Scientific Conferences/Congresses, KOL Panels and Clinical Trial Steering Groups, in order to maintain and build relationships with KOLs and the wider clinical community.

Be a 'voice' for field teams within the Pfizer Oncology organization, ensuring that field medical perspectives are transmitted to discussions of clinical development are integrated into strategy development to support launch and post-launch success.

BASIC QUALIFICATIONS
Clinically trained (MD, ClinPharm), PharmD, MD-PhD desired

Oncology medical professional with strong experience (at least 9 years if MD, ClinPharm or MD-PhD, at least 15 years if PhD or PharmD) in the pharmaceutical or biopharma industry with clinical development, and/or medical affairs experience.

A leader who can work collaboratively across a complex cross functional team of stakeholders. Must be able to lead with a lightspeed, innovative, and entrepreneurial mindset.

Extensive experience and strong understanding of biopharmaceutical drug development, the competitive landscape / oncology market dynamics / evolving treatment landscape and HCP and patient insights, bringing deep clinical and external stakeholder insights to decision making.

A recognised leader in the breast cancer medical field, able to build and maintain strong relationships with senior academics, investigators and KOLs.

Proven expertise in fostering employee development and well-being through effective people development, and motivational team leadership.

A strong ability to influence all levels of the organization, including both senior-level colleagues and other levels across the company.

Must have executive leadership skills, able to lead and motivate a team of medical experts that have strong knowledge in oncology and are medical leaders on the Global Medicine Teams.

A strategic leader, able to work within a matrix organization with a high proficiency in problem solving, strong analytical skills and an ability to lead through complexity and ambiguity.

The annual base salary for this position ranges from $299,600.00 to $499, In addition, this position is eligible for participation in Pfizer's Global Performance Plan with a bonus target of 30.0% of the base salary and eligibility to participate in our share based long term incentive program.

We offer comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support each of life's moments.

Benefits offered include a 401(k) plan with Pfizer Matching Contributions and an additional Pfizer Retirement Savings Contribution, paid vacation, holiday and personal days, paid caregiver/parental and medical leave, and health benefits to include medical, prescription drug, dental and vision coverage.

Learn more at Pfizer Candidate Site – U.S. Benefits | ). Pfizer compensation structures and benefit packages are aligned based on the location of hire.

The United States salary range provided does not apply to Tampa, FL or any location outside of the United States.

Relocation assistance may be available based on business needs and/or eligibility.
Sunshine Act

Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations.

These laws and regulations require Pfizer to provide government agencies with information such as a health care provider's name, address and the type of payments or other value received, generally for public disclosure.

Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act.

Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government.

If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.
EEO & Employment Eligibility

Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status.

Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA.

Pfizer is an E-Verify employer. This position requires permanent work authorization in the United States.
Medical
#J-18808-Ljbffr

---